Piramal Pharma Limited (BOM:543635)
India · Delayed Price · Currency is INR 232.80
+34.35 (17.31%)
At close: Oct 28, 2026
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 309.45 billion as of October 28, 2026. Its market cap has increased by 14.72% in one year.
Market Cap
309.45B
Enterprise Value
360.11B
Revenue
97.79B
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 309.45B, an increase of 36.48%. That is a compound annual growth rate of 8.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 309.45B | 35.33% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 502.54B |
| Gland Pharma | 488.35B |
| Ajanta Pharma | 418.98B |
| Emcure Pharmaceuticals | 355.69B |
| Wockhardt | 306.27B |
| Piramal Pharma | 264.15B |
| Cohance Lifesciences | 183.36B |
| Eris Lifesciences | 166.26B |